Cognex (NASDAQ:CGNX) Stock Rating Lowered by Zacks Research

Cognex (NASDAQ:CGNX – Get Free Report) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks reports.

A number of other analysts have also recently weighed in on CGNX. DA Davidson reaffirmed a “neutral” rating and issued a $65.00 price objective on shares of Cognex in a report on Wednesday, September 23rd. Needham & Company LLC reissued a “buy” rating and set a $80.00 target price on shares of Cognex in a research note on Tuesday, September 15th. Truist Financial set a $74.00 target price on shares of Cognex and gave the stock a “hold” rating in a research report on Monday. Robert W. Baird dropped their price target on shares of Cognex from $78.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 23rd. Finally, Barclays reaffirmed an “overweight” rating and set a $80.00 price target (up from $75.00) on shares of Cognex in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.21.

Get Our Latest Analysis on CGNX

Cognex Price Performance

Cognex stock opened at $61.21 on Tuesday. Cognex has a 12 month low of $34.60 and a 12 month high of $72.88. The company has a fifty day moving average price of $62.26 and a two-hundred day moving average price of $61.20. The company has a market cap of $10.30 billion, a PE ratio of 59.43 and a beta of 1.48.

Cognex (NASDAQ:CGNX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The company had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. During the same period last year, the firm posted $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities research analysts anticipate that Cognex will post 1.68 earnings per share for the current year.

Hedge Funds Weigh In On Cognex

Institutional investors and hedge funds have recently bought and sold shares of the stock. Elevation Wealth Partners LLC raised its position in shares of Cognex by 86.6% during the 3rd quarter. Elevation Wealth Partners LLC now owns 892 shares of the scientific and technical instruments company’s stock worth $54,000 after buying an additional 414 shares in the last quarter. Congress Asset Management Co. bought a new position in shares of Cognex in the third quarter valued at approximately $23,624,000. Eastern Bank boosted its holdings in shares of Cognex by 20.0% in the third quarter. Eastern Bank now owns 1,242 shares of the scientific and technical instruments company’s stock valued at $75,000 after acquiring an additional 207 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cognex by 5,143.8% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 57,944 shares of the scientific and technical instruments company’s stock valued at $3,514,000 after acquiring an additional 56,839 shares during the period. Finally, Versant Capital Management Inc increased its stake in shares of Cognex by 16.9% during the third quarter. Versant Capital Management Inc now owns 9,497 shares of the scientific and technical instruments company’s stock valued at $576,000 after acquiring an additional 1,376 shares during the period. Institutional investors own 88.12% of the company’s stock.

About Cognex

(Get Free Report)

Cognex Corporation (NASDAQ: CGNX) develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company’s product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.

See Also

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.